Alabama Academy of Family Physicians
MAY 15, 2025
HB 86 – Rural Hospital Investment Fund Bill What’s in the Bill: Sponsored by Rep. Terri Collins, HB 86 proposes the establishment of a Rural Hospital Investment Program in Alabama, which would serve as a conduit for financial support from the public directed towards rural hospitals in the state.
My Green Doctor
MAY 3, 2025
That’s why our Practice Management program includes a guided, meeting-by-meeting path for helping clinics transition to renewable energy and cut utility bills—without overwhelming staff or adding to your to-do list. hospital upwards of $240,000 over 5 years. hospital could save $240,000 per year.” 3 “Each U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FDA Law Blog
JULY 17, 2022
Currently, a health care provider identifies any discarded quantity from such a vial in the claim using a JW modifier, and Medicare Part B pays for both the utilized and the discarded amount. The manufacturer responsible for paying the refunds will be the company whose NDC is on the label.
GeriPal
MAY 5, 2022
Association of Sensory and Cognitive Impairment With Healthcare Utilization and Cost in Older Adults. Including more hospital utilization or healthcare utilization, maybe cognitive impairment issues. My own work focuses on hospitalization and health utilization over time. Is that right? Is that right, Nick?
Alabama Academy of Family Physicians
FEBRUARY 19, 2025
Running from February 4 to May 15, this session promises to bring substantial changes to medical consent laws, Medicaid coverage, rural hospital funding, taxation on essential goods, and the transparency of healthcare costs. HB 86 – Rural Hospital Investment Fund Bill What’s in the Bill: Sponsored by Rep.
FDA Law Blog
OCTOBER 16, 2024
To that end, FDA approved the MSN ANDA without the modified dosing regimen and with the indication “to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure and reduced ejection fraction.
FDA Law Blog
SEPTEMBER 30, 2024
CMS did not finalize the price verification survey, which would have required manufacturers of 10 costly drugs selected annually to provide clinical information as well as information on production, distribution, research, and marketing costs, revenue and profit, and ex-U.S. Remarkably, manufacturers may not dispute a CMS notification.
Expert insights. Personalized for you.
130 
Let's personalize your content